A Maine federal judge tossed out a woman’s lawsuit against Merck (NYSE:MRK), after she claimed that the company’s Nexplanon birth control implant allegedly failed to keep her from becoming pregnant.
Kayla Doherty filed the suit in April 2015, seeking damages related to the costs of raising a child as a single mother and costs related to her pregnancy. But Merck pointed to Maine’s Wrongful Birth Statute, which blocks damages arising from the birth of a healthy child.
Get the full story at our sister site, Drug Delivery Business News.
The post Federal judge dismisses faulty birth control suit against Merck appeared first on MassDevice.
from MassDevice http://ift.tt/2vnmAqS
Cap comentari:
Publica un comentari a l'entrada